INTUITIVE SURGICAL INC ISRG
Nasdaq · XNAS · stock · Orthopedic, Prosthetic & Surgical Appliances & Supplies
Chart by TradingView
7/9
Piotroski F — financial health
12.01
Altman Z″ — distress risk · safe
—
Dividend payout · no dividend
Financials (annual, from 10-K)
| FY | Revenue | Net income | Gross profit | Free cash flow | Equity |
|---|---|---|---|---|---|
| 2025 | $10.1B | $2.9B | $6.6B | — | $17.8B |
| 2024 | $8.4B | $2.3B | $5.6B | — | $16.5B |
| 2023 | $7.1B | $1.8B | $4.7B | — | $13.4B |
| 2022 | $6.2B | $1.3B | $4.2B | — | $11.1B |
| 2021 | $5.7B | $1.7B | $4.0B | — | $12.0B |
| 2020 | $4.4B | $1.1B | $2.9B | — | $9.8B |
Recent insider activity (Form 4)
| Insider | Role | Date | Action | Shares | Price |
|---|---|---|---|---|---|
| Brosius Mark | EVP & Chief Mfg and Supply Cha | 2026-06-12 | Sell | 25 | $414.13 |
| Brosius Mark | EVP & Chief Mfg and Supply Cha | 2026-06-11 | Sell | 23 | $412.16 |
| LOEB GARY | EVP & Chief Legal and Complian | 2026-06-10 | Sell | 400 | $424.14 |
| Brosius Mark | EVP & Chief Mfg and Supply Cha | 2026-06-10 | Sell | 23 | $424.14 |
| Rosa David J. | Chief Executive Officer (CEO) | 2026-06-10 | Tax withheld | 674 | $426.61 |
| Rosa David J. | Chief Executive Officer (CEO) | 2026-06-10 | Option exercise | 1,358 | — |
| Brosius Mark | EVP & Chief Mfg and Supply Cha | 2026-06-09 | Sell | 23 | $421.13 |
| Brosius Mark | EVP & Chief Mfg and Supply Cha | 2026-06-08 | Sell | 23 | $420.12 |
Why these scores methodology →
Piotroski F-score: 7/9
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″: 12.01 (safe)
- Working capital / assets 0.38
- Retained earnings / assets 0.343
- EBIT / assets 0.144
- Equity / liabilities 7.081
Source: SEC EDGAR filings · CIK 0001035267 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.